A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
NCT07139535 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 350
Last updated 2025-08-24
Summary
The goal for this study is to evaluate the efficacy and safety of RAY1225 versus placebo in participants with type 2 diabetes not under control with diet and exercise alone.
Conditions
- T2DM
Interventions
- DRUG
-
RAY1225
Administered SC
- DRUG
-
Administered SC
Sponsors & Collaborators
-
Guangdong Raynovent Biotech Co., Ltd
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-31
- Primary Completion
- 2026-12-01
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects
NCT03520972 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control
NCT00621140 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus
NCT07073170 ·Status: COMPLETED ·Phase: PHASE1
-
Adult Subjects With Uncontrolled Type 2 Diabetes
NCT02317796 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes
NCT02212925 ·Status: TERMINATED ·Phase: PHASE1
-
The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
NCT01342042 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone
NCT00995345 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
NCT05158244 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes
NCT05063253 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus
NCT06258148 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
NCT06254014 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus
NCT01792635 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants
NCT06869018 ·Status: COMPLETED ·Phase: PHASE1
-
Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes
NCT01285518 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes
NCT02653599 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Rivoglitazone in Type 2 Diabetes Mellitus
NCT00484198 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects
NCT00162305 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus
NCT01044537 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 Diabetes
NCT01282970 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of ZT002 Injection in Adult Chinese Subjects With Type 2 Diabetes Mellitus (T2DM)
NCT07065032 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes
NCT02222350 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone
NCT00525330 ·Status: COMPLETED ·Phase: PHASE2
-
A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes
NCT01469065 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY2189265 in Japanese Patients With Type 2 Diabetes
NCT01001104 ·Status: COMPLETED ·Phase: PHASE2
-
Amlexanox for Type 2 Diabetes and Obesity
NCT01842282 ·Status: TERMINATED ·Phase: PHASE2